Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104 · see citing works

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603 · see citing works

Diagnosis of multiple cancer types by shrunken centroids of gene expression

Tibshirani, R. J., Hastie, T. J., Narasimhan, B., & Chu, G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082099299 · Cited by 2,938 · see citing works

GenePattern 2.0

Reich, M. M., Liefeld, T., Gould, J., Lerner, J., Tamayo, P., & Mesirov, J. P. (2006) · Nature Genetics · doi:10.1038/ng0506-500 · Cited by 2,035 · see citing works

Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data

Dai, M. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni179 · Cited by 1,797 · see citing works

Cytochrome P450 and Chemical Toxicology

Guengerich, F. P. (2007) · Chemical Research in Toxicology · doi:10.1021/tx700079z · Cited by 1,726 · see citing works

Benzo[alpha]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes.

Gelboin, H. V. (1980) · Physiological Reviews · doi:10.1152/physrev.1980.60.4.1107 · Cited by 1,280 · see citing works

Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties

Wilkening, S., Stahl, F., & Bader, A. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.8.1035 · Cited by 794 · see citing works

The human hepatoma HepaRG cells: A highly differentiated model for studies of liver metabolism and toxicity of xenobiotics

Guillouzo, A., Corlu, A., Aninat, C., Glaise, D., Morel, F., & Guguen‐Guillouzo, C. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.12.003 · Cited by 675 · see citing works

Cytochrome P450-mediated metabolism of estrogens and its regulation in human

Tsuchiya, Y., Nakajima, M., & Yokoi, T. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.10.007 · Cited by 616 · see citing works

Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells

Westerink, W. M. A., & Schoonen, W. G. E. J. (2007) · Toxicology in Vitro · doi:10.1016/j.tiv.2007.05.014 · Cited by 544 · see citing works

Use of metabolically competent human hepatoma cells for the detection of mutagens and antimutagens

Knasmüller, S., Parzefall, W., Sanyal, R., Ecker, S., Schwab, C., Uhl, M., Mersch‐Sundermann, V., Williamson, G., Hietsch, G., Langer, T., et al. (1998) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(97)00297-2 · Cited by 415 · see citing works

Evaluation of HepaRG Cells as an in Vitro Model for Human Drug Metabolism Studies

Kanebratt, K. P., & Andersson, T. B. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.020016 · Cited by 355 · see citing works

Regulation, Function, and Tissue-Specific Expression of Cytochrome P450 CYP1B1

Murray, G. I., Melvin, W. T., Greenlee, W. F., & Burke, M. D. (2001) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.297 · Cited by 337 · see citing works

Toxicogenomics-Based Discrimination of Toxic Mechanism in HepG2 Human Hepatoma Cells

Burczynski, M. E. (2000) · Toxicological Sciences · doi:10.1093/toxsci/58.2.399 · Cited by 253 · see citing works

p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines

Hsu, I., Tokiwa, T., Bennett, W. P., Metcalf, R. A., Welsh, J. A., Sun, T., & Harris, C. C. (1993) · Carcinogenesis · doi:10.1093/carcin/14.5.987 · Cited by 242 · see citing works

Phase II enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells

Westerink, W. M. A., & Schoonen, W. G. E. J. (2007) · Toxicology in Vitro · doi:10.1016/j.tiv.2007.06.017 · Cited by 226 · see citing works

ArrayTrack--supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for Toxicological Research.

Tong, W., Cao, X. M., Harris, S., Sun, H., Fang, H., Fuscoe, J. C., Harris, A. J., Hong, H., Xie, Q., Perkins, R., et al. (2003) · Environmental Health Perspectives · doi:10.1289/ehp.6497 · Cited by 219 · see citing works

HepaRG Cells as an in Vitro Model for Evaluation of Cytochrome P450 Induction in Humans

Kanebratt, K. P., & Andersson, T. B. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.017418 · Cited by 216 · see citing works

Discrimination of genotoxic from non-genotoxic carcinogens by gene expression profiling

van Delft, J. H. M. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh108 · Cited by 158 · see citing works

Molecular mechanisms mediating the G protein-coupled receptor regulation of cell cycle progression

New, D. C., & Wong, Y. H. (2007) · Journal of Molecular Signaling · doi:10.1186/1750-2187-2-2 · Cited by 155 · see citing works

Dominant Contribution of P450 3A4 to the Hepatic Carcinogenic Activation of Aflatoxin B1

Kamdem, L. K., Meineke, I., Gödtel‐Armbrust, U., Brockmöller, J., & Wojnowski, L. (2006) · Chemical Research in Toxicology · doi:10.1021/tx050358e · Cited by 153 · see citing works

Gene expression profiling and differentiation assessment in primary human hepatocyte cultures, established hepatoma cell lines, and human liver tissues

Goyak, K. O., Page, J. L., Johnson, M. C., Zarbl, H., Strom, S. C., & Omiecinski, C. J. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.03.032 · Cited by 136 · see citing works

PREDICTIVE VALUE OF IN VITRO MODEL SYSTEMS IN TOXICOLOGY

Davila, J. C., Rodriguez, R. J., Melchert, R. B., & Acosta, D. (1998) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.63 · Cited by 130 · see citing works

Time- and concentration-dependent changes in gene expression induced by benzo(a)pyrene in two human cell lines, MCF-7 and HepG2

Hockley, S. L., Arlt, V. M., Brewer, D. S., Giddings, I., & Phillips, D. H. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-260 · Cited by 124 · see citing works

Functional expression, inhibition and induction of CYP enzymes in HepaRG cells

Turpeinen, M., Tolonen, A., Chesné, C., Guillouzo, A., Uusitalo, J., & Pelkonen, O. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.03.008 · Cited by 117 · see citing works

Comparison of basal gene expression profiles and effects of hepatocarcinogens on gene expression in cultured primary human hepatocytes and HepG2 cells

Harris, A. J., Dial, S. L., & Casciano, D. A. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2003.11.014 · Cited by 109 · see citing works

Development of public toxicogenomics software for microarray data management and analysis

Tong, W., Harris, S., Cao, X. M., Fang, H., Shi, L. M., Sun, H., Fuscoe, J. C., Harris, A. J., Hong, H., Xie, Q., et al. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2003.12.024 · Cited by 107 · see citing works

11th Report on Carcinogens.

(2004) · PubMed · Cited by 102 · see citing works

The use of genomics technology to investigate gene expression changes in cultured human liver cells

Harries, H. M., Fletcher, S., Duggan, C. M., & Baker, V. A. (2001) · Toxicology in Vitro · doi:10.1016/s0887-2333(01)00043-1 · Cited by 100 · see citing works

Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells

Lambert, C. B., Spire, C., Claude, N., & Guillouzo, A. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.11.008 · Cited by 90 · see citing works

Metabolism of Benzo[a]pyrene in Human Bronchoalveolar H358 Cells Using Liquid Chromatography–Mass Spectrometry

Jiang, H., Gelhaus, S. L., Mangal, D., Harvey, R. G., Blair, I. A., & Penning, T. M. (2007) · Chemical Research in Toxicology · doi:10.1021/tx700107z · Cited by 88 · see citing works

Trovafloxacin-Induced Gene Expression Changes in Liver-Derived in Vitro Systems: Comparison of Primary Human Hepatocytes to HepG2 Cells

Liguori, M. J., Blomme, E. A. G., & Waring, J. F. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.017608 · Cited by 84 · see citing works

The role of cytochromes P-450 in cyclosporine metabolism

Watkins, P. B. (1990) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(90)70358-o · Cited by 81 · see citing works

Comparison of supervised clustering methods to discriminate genotoxic from non-genotoxic carcinogens by gene expression profiling

van Delft, J. H. M., van Agen, E., Breda, S. G. J. V., van Herwijnen, M. H. M., Staal, Y. C. M., & Kleinjans, J. C. S. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2005.02.006 · Cited by 76 · see citing works

Purification and characterization of an anticonvulsant-induced human cytochrome P-450 catalysing cyclosporin metabolism

Shaw, P. M., Barnes, T. S., Cameron, D., Engeset, J., Melvin, W. T., Omar, G., Petrie, J. C., Rush, W. R., Snyder, C. P., Whiting, P. H., et al. (1989) · Biochemical Journal · doi:10.1042/bj2630653 · Cited by 49 · see citing works

Compared Effect of Immunosuppressive Drugs Cyclosporine A and Rapamycin on Cholesterol Homeostasis Key Enzymes CYP27A1 and HMG‐CoA Reductase

Guéguen, Y., Ferrari, L., Souidi, M., Batt, A., Lutton, C., Siest, G., & Visvikis‐Siest, S. (2007) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2007.00066.x · Cited by 41 · see citing works

Inhibition of aryl hydrocarbon receptor transactivation and DNA adduct formation by CYP1 isoform-selective metabolic deactivation of benzo[a]pyrene

Endo, K., Uno, S., Seki, T., Ariga, T., Kusumi, Y., Mitsumata, M., Yamada, S., & Makishima, M. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.02.009 · Cited by 41 · see citing works

Discriminating two classes of toxicants through expression analysis of HepG2 cells with DNA arrays

Hong, Y., Müller, U. R., & Lai, F. (2003) · Toxicology in Vitro · doi:10.1016/s0887-2333(02)00122-4 · Cited by 38 · see citing works

NuGO contributions to GenePattern

de Groot, P. J., Reiff, C., Mayer, C., & Müller, M. M. (2008) · Genes & Nutrition · doi:10.1007/s12263-008-0093-2 · Cited by 27 · see citing works

Bile acid synthesis in HepG2 cells: effect of cyclosporin

Levy, J., Budai, K., & Javitt, N. B. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39774-1 · Cited by 19 · see citing works

Modulation of metabolism in HepG2 cells upon treatment with cyclosporin A and Nva2-cyclosporin

Bäckman, L., Appelkvist, E. L., Sundberg, Å. L., Teclebrhan, H., & Brunk, U. T. (1991) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(91)90034-u · Cited by 14 · see citing works

Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins

Gerets, H. H. J., Tilmant, K., Gerin, B., Chanteux, H., Depelchin, B. O., Dhalluin, S., & Atienzar, F. A. (2012) · Cell Biology and Toxicology · doi:10.1007/s10565-011-9208-4 · Cited by 698 · see citing works

A liver-on-a-chip platform with bioprinted hepatic spheroids

Bhise, N. S., Manoharan, V., Massa, S., Tamayol, A., Ghaderi, M., Miscuglio, M., Lang, Q., Shrike Zhang, Y., Shin, S. R., Calzone, G., et al. (2016) · Biofabrication · doi:10.1088/1758-5090/8/1/014101 · Cited by 615 · see citing works

The Curious Case of the HepG2 Cell Line: 40 Years of Expertise

Arzumanian, V. A., Kiseleva, O. I., & Poverennaya, E. V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313135 · Cited by 387 · see citing works

Organotypic liver culture models: meeting current challenges in toxicity testing

LeCluyse, E. L., Witek, R. P., Andersen, M. E., & Powers, M. J. (2012) · Critical Reviews in Toxicology · doi:10.3109/10408444.2012.682115 · Cited by 363 · see citing works

Similarities and differences in the expression of drug-metabolizing enzymes between human hepatic cell lines and primary human hepatocytes

Guo, L., Dial, S., Shi, L., Branham, W., Liu, J., Fang, J.-L., Green, B., Deng, H., Kaput, J., & Ning, B. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.035873 · Cited by 348 · see citing works

Novel 3D Culture Systems for Studies of Human Liver Function and Assessments of the Hepatotoxicity of Drugs and Drug Candidates

Lauschke, V. M., Hendriks, D. F. G., Bell, C. C., Andersson, T. B., & Ingelman-Sundberg, M. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00150 · Cited by 226 · see citing works

The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma

Huang, J.-L., Cao, S., Ou, Q., Yang, B., Zheng, S., Tang, J. Y., Chen, J., Hu, Y., Zheng, L., & Wang, Q. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0841-x · Cited by 214 · see citing works

Optimization of the HepaRG cell model for drug metabolism and toxicity studies

Anthérieu, S., Chesné, C., Li, R., Guguen‐Guillouzo, C., & Guillouzo, A. (2012) · Toxicology in Vitro · doi:10.1016/j.tiv.2012.05.008 · Cited by 177 · see citing works

Design and fabrication of a liver-on-a-chip platform for convenient, highly efficient, and safe in situ perfusion culture of 3D hepatic spheroids

Ma, L.-D., Wang, Y., Wang, J., Wu, J., Meng, X., Hu, P., Mu, X., Liang, Q., & Luo, G. (2018) · Lab on a Chip · doi:10.1039/c8lc00333e · Cited by 167 · see citing works

Comparative cytotoxicity of nanosilver in human liver HepG2 and colon Caco2 cells in culture

Sahu, S. C., Zheng, J., Graham, L., Chen, L., Ihrie, J., Yourick, J. J., & Sprando, R. L. (2014) · Journal of Applied Toxicology · doi:10.1002/jat.2994 · Cited by 162 · see citing works

A Comprehensive Statistical Analysis of Predicting In Vivo Hazard Using High-Throughput In Vitro Screening

Thomas, R. S., Black, M. B., Li, L., Healy, E., Chu, T., Bao, W., Andersen, M. E., & Wolfinger, R. D. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs159 · Cited by 148 · see citing works

In Vitro Models for Non-Alcoholic Fatty Liver Disease: Emerging Platforms and Their Applications

Ramos, M. J., Bandiera, L., Menolascina, F., & Fallowfield, J. A. (2022) · iScience · doi:10.1016/j.isci.2021.103549 · Cited by 127 · see citing works

Metabolic characterization of cell systems used in in vitro toxicology testing: Lung cell system BEAS-2B as a working example

Garcia‐Canton, C., Minet, E., Anadón, A., & Meredith, C. (2013) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.05.001 · Cited by 118 · see citing works

Computational toxicology in drug discovery: applications of artificial intelligence in ADMET and toxicity prediction

Zhang, J., Li, H., Zhang, Y., Huang, J., Ren, L., Zhang, C., Zou, Q., & Zhang, Y. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf533 · Cited by 125 · see citing works

Dioxin toxicity, aryl hydrocarbon receptor signaling, and apoptosis—Persistent pollutants affect programmed cell death

Chopra, M., & Schrenk, D. (2011) · Critical Reviews in Toxicology · doi:10.3109/10408444.2010.524635 · Cited by 113 · see citing works

Proteomics Investigations of Drug-Induced Hepatotoxicity in HepG2 Cells

Summeren, A. V., Renes, J., Bouwman, F. G., Noben, J., van Delft, J. H. M., Kleinjans, J. C. S., & Mariman, E. C. M. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq380 · Cited by 108 · see citing works

Comparative Gene Expression Profiles Induced by PPARγ and PPARα/γ Agonists in Human Hepatocytes

Rogue, A., Lambert, C. B., Jossé, R., Anthérieu, S., Spire, C., Claude, N., & Guillouzo, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018816 · Cited by 105 · see citing works

Comparative Proteomic Characterization of 4 Human Liver-Derived Single Cell Culture Models Reveals Significant Variation in the Capacity for Drug Disposition, Bioactivation, and Detoxication

Sison-Young, R. L. C., Mitsa, D., Jenkins, R. E., Mottram, D. R., Alexandre, E., Richert, L., Aerts, H., Weaver, R. J., Jones, R. P., Johann, E., et al. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv136 · Cited by 96 · see citing works

Comparison of Liver Cell Models Using the Basel Phenotyping Cocktail

Berger, B., Donzelli, M., Maseneni, S., Boess, F., Roth, A. B., Krähenbühl, S., & Haschke, M. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00443 · Cited by 92 · see citing works

Exploring the zebrafish embryo as an alternative model for the evaluation of liver toxicity by histopathology and expression profiling

Driessen, M., Kienhuis, A. S., Pennings, J. L. A., Pronk, T. E., van den Brandhof, E., Roodbergen, M., Spaink, H. P., van de Water, B., & van der Ven, L. T. M. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1039-z · Cited by 89 · see citing works

A transcriptomics-based in vitro assay for predicting chemical genotoxicity in vivo

Magkoufopoulou, C., Claessen, S. M. H., Tsamou, M., Jennen, D. G. J., Kleinjans, J. C. S., & van Delft, J. H. M. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs182 · Cited by 86 · see citing works

An untargeted multi-technique metabolomics approach to studying intracellular metabolites of HepG2 cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin

Ruiz‐Aracama, A., Peijnenburg, A., Kleinjans, J. C. S., Jennen, D. G. J., van Delft, J. H. M., Hellfrisch, C., & Lommen, A. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-251 · Cited by 84 · see citing works

γH2AX as a novel endpoint to detect DNA damage: Applications for the assessment of the in vitro genotoxicity of cigarette smoke

Garcia‐Canton, C., Anadón, A., & Meredith, C. (2012) · Toxicology in Vitro · doi:10.1016/j.tiv.2012.06.006 · Cited by 77 · see citing works

RNA-Seq Provides New Insights in the Transcriptome Responses Induced by the Carcinogen Benzo[a]pyrene

van Delft, J. H. M., Gaj, S., Lienhard, M., Albrecht, M. W., Кирпий, А. А., Brauers, K. J. J., Claessen, S. M. H., Lizárraga, D., Lehrach, H. R., Herwig, R., et al. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs250 · Cited by 74 · see citing works

Cytotoxicity and Apoptosis Induced by a Plumbagin Derivative in Estrogen Positive MCF-7 Breast Cancer Cells

Sagar, S., Esau, L. E., Moosa, B., Khashab, N. M., Bajić, V. B., & Kaur, M. (2014) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/18715206113136660369 · Cited by 74 · see citing works

Experimental liver models: From cell culture techniques to microfluidic organs‐on‐chip

Polidoro, M. A., Ferrari, E., Marzorati, S., Lleò, A., & Rasponi, M. (2021) · Liver International · doi:10.1111/liv.14942 · Cited by 76 · see citing works

Interindividual Variability in Gene Expression Profiles in Human Hepatocytes and Comparison with HepaRG Cells

Rogue, A., Lambert, C. B., Spire, C., Claude, N., & Guillouzo, A. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.042028 · Cited by 72 · see citing works

Benchmarking Water Quality from Wastewater to Drinking Waters Using Reduced Transcriptome of Human Cells

Xia, P., Zhang, X., Zhang, H., Wang, P., Tian, M., & Yu, H. (2017) · Environmental Science & Technology · doi:10.1021/acs.est.7b02648 · Cited by 72 · see citing works

Grouping 34 Chemicals Based on Mode of Action Using Connectivity Mapping

Abrew, K. N. D., Kainkaryam, R. M., Shan, Y. K., Overmann, G. J., Settivari, R. S., Wang, X., Xu, J., Adams, R. L., Tiesman, J. P., Carney, E. W., et al. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw058 · Cited by 70 · see citing works

Human Embryonic Stem Cell Derived Hepatocyte-Like Cells as a Tool for In Vitro Hazard Assessment of Chemical Carcinogenicity

Yildirimman, R., Brolén, G., Vilardell, M., Eriksson, G., Synnergren, J., Gmuender, H., Kamburov, A., Ingelman‐Sundberg, M., Castell, J. V., Lahoz, A., et al. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr225 · Cited by 63 · see citing works

Differences in TCDD-elicited gene expression profiles in human HepG2, mouse Hepa1c1c7 and rat H4IIE hepatoma cells

Dere, E., Lee, A. W., Burgoon, L. D., & Zacharewski, T. R. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-193 · Cited by 62 · see citing works

Impact of cell types and culture methods on the functionality of in vitro liver systems – A review of cell systems for hepatotoxicity assessment

Kyffin, J. A., Sharma, P., Leedale, J., Colley, H. E., Murdoch, C., Mistry, P., & Webb, S. D. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.01.023 · Cited by 61 · see citing works

Identification of early target genes of aflatoxin B1 in human hepatocytes, inter-individual variability and comparison with other genotoxic compounds

Jossé, R., Dumont, J., Fautrel, A., Robin, M., & Guillouzo, A. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.10.019 · Cited by 60 · see citing works

Three-Dimensional Liver Culture Systems to Maintain Primary Hepatic Properties for Toxicological Analysis In Vitro

Kammerer, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910214 · Cited by 59 · see citing works

Comparison of protein expression between human livers and the hepatic cell lines HepG2, Hep3B, and Huh7 using SWATH and MRM-HR proteomics: Focusing on drug-metabolizing enzymes

Shi, J., Wang, X., Lyu, L., Jiang, H., & Zhu, H. (2018) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2018.03.003 · Cited by 59 · see citing works

Xenobiotic metabolism in differentiated human bronchial epithelial cells

Boei, J. J. W. A., Vermeulen, S., Klein, B., Hiemstra, P. S., Verhoosel, R. M., Jennen, D. G. J., Lahoz, A., Gmuender, H., & Vrieling, H. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1868-7 · Cited by 58 · see citing works

Human Skin-Derived Stem Cells as a Novel Cell Source for In Vitro Hepatotoxicity Screening of Pharmaceuticals

Rodrigues, R. M., Kock, J. D., Branson, S., Vinken, M., Meganathan, K., Chaudhari, U., Sachinidis, A., Govaere, O., Roskams, T., Boe, V. D., et al. (2013) · Stem Cells and Development · doi:10.1089/scd.2013.0157 · Cited by 57 · see citing works

Baseline and genotoxic compound induced gene expression profiles in HepG2 and HepaRG compared to primary human hepatocytes

Jetten, M. J. A., Kleinjans, J. C. S., Claessen, S. M. H., Chesné, C., & van Delft, J. H. M. (2013) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.07.010 · Cited by 57 · see citing works

A review on ochratoxin A transcriptomic studies

Vettorazzi, A., van Delft, J. H. M., & de Ceráin, A. L. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.05.043 · Cited by 57 · see citing works

Transcriptomic responses generated by hepatocarcinogens in a battery of liver-based in vitro models

Doktorova, T. Y., Yildirimman, R., Vinken, M., Vilardell, M., Vanhaecke, T., Gmuender, H., Bort, R., Brolén, G., Holmgren, G., Li, R., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt054 · Cited by 55 · see citing works

Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells

Magkoufopoulou, C., Claessen, S. M. H., Jennen, D. G. J., Kleinjans, J. C. S., & van Delft, J. H. M. (2011) · Mutagenesis · doi:10.1093/mutage/ger021 · Cited by 53 · see citing works

Thyroid hormone induction of human cholesterol 7 alpha-hydroxylase (Cyp7a1) in vitro

Lindemann, J. A. L., Angajala, A., Engler, D. A., Webb, P., & Ayers, S. D. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.02.003 · Cited by 52 · see citing works

Metabolic and phenotypic changes induced by PFAS exposure in two human hepatocyte cell models

Alijagić, A., Sinisalu, L., Duberg, D., Kotlyar, O., Scherbak, N. N., Engwall, M., Orešič, M., & Hyötyläinen, T. (2024) · Environment International · doi:10.1016/j.envint.2024.108820 · Cited by 50 · see citing works

Environmental epitranscriptomics

Çayır, A., Byun, H., & Barrow, T. M. (2020) · Environmental Research · doi:10.1016/j.envres.2020.109885 · Cited by 49 · see citing works

Human hepatocyte systems for in vitro toxicology analysis

Kammerer, S., & Küpper, J. (2018) · Journal of Cellular Biotechnology · doi:10.3233/jcb-179012 · Cited by 48 · see citing works

Epigenetic mechanisms underlying arsenic-associated lung carcinogenesis

Breda, S. G. J. V., Claessen, S. M. H., Lo, K. C., van Herwijnen, M. H. M., Brauers, K. J. J., Lisanti, S., Theunissen, D. H. J., Jennen, D. G. J., Gaj, S., de Kok, T. M. C. M., et al. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1351-2 · Cited by 47 · see citing works

Development of novel tools for thein vitroinvestigation of drug-induced liver injury

Jiang, J., Wolters, J. E. J., Breda, S. G. J. V., Kleinjans, J. C. S., & de Kok, T. M. C. M. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.1065814 · Cited by 46 · see citing works

Quantitative comparison of in vitro genotoxicity between metabolically competent HepaRG cells and HepG2 cells using the high-throughput high-content CometChip assay

Seo, J., Tryndyak, V., Wu, Q., Dreval, K., Pogribny, I. P., Bryant, M., Zhou, T., Robison, T. W., Mei, N., & Guo, X. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02406-9 · Cited by 46 · see citing works

Toxicogenomic responses of human liver HepG2 cells to silver nanoparticles

Sahu, S. C., Zheng, J., Yourick, J. J., Sprando, R. L., & Gao, X. (2015) · Journal of Applied Toxicology · doi:10.1002/jat.3170 · Cited by 45 · see citing works

Integrating transcriptomics and metabonomics to unravel modes-of-action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in HepG2 cells

Jennen, D. G. J., Ruiz‐Aracama, A., Magkoufopoulou, C., Peijnenburg, A., Lommen, A., van Delft, J. H. M., & Kleinjans, J. C. S. (2011) · BMC Systems Biology · doi:10.1186/1752-0509-5-139 · Cited by 45 · see citing works

Time series analysis of oxidative stress response patterns in HepG2: A toxicogenomics approach

Deferme, L., Briedé, J. J., Claessen, S. M. H., Jennen, D. G. J., Cavill, R., & Kleinjans, J. C. S. (2013) · Toxicology · doi:10.1016/j.tox.2013.02.001 · Cited by 44 · see citing works

MicroRNA Responses to the Genotoxic Carcinogens Aflatoxin B1and Benzo[a]pyrene in Human HepaRG Cells

Marrone, A. K., Tryndyak, V., Beland, F. A., & Pogribny, I. P. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv253 · Cited by 44 · see citing works

Effects of usnic acid exposure on human hepatoblastoma HepG2 cells in culture

Sahu, S. C., Amankwa‐Sakyi, M., O'Donnell, M. W., & Sprando, R. L. (2011) · Journal of Applied Toxicology · doi:10.1002/jat.1721 · Cited by 44 · see citing works

Performance of in vitro γH2AX assay in HepG2 cells to predict in vivo genotoxicity

Tsamou, M., Jennen, D. G. J., Claessen, S. M. H., Magkoufopoulou, C., Kleinjans, J. C. S., & van Delft, J. H. M. (2012) · Mutagenesis · doi:10.1093/mutage/ges030 · Cited by 43 · see citing works

Characterisation of a functional rat hepatocyte spheroid model

Kyffin, J. A., Sharma, P., Leedale, J., Colley, H. E., Murdoch, C., Harding, A. L., Mistry, P., & Webb, S. D. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.12.014 · Cited by 43 · see citing works

Two persistent organic pollutants which act through different xenosensors (alpha-endosulfan and 2,3,7,8 tetrachlorodibenzo-p-dioxin) interact in a mixture and downregulate multiple genes involved in human hepatocyte lipid and glucose metabolism

Ambolet-Camoit, A., Ottolenghi, C., Leblanc, A. F., Kim, M. J., Letourneur, F., Jacques, S., Cagnard, N., Guguen‐Guillouzo, C., Barouki, R., & Aggerbeck, Μ. (2015) · Biochimie · doi:10.1016/j.biochi.2015.07.003 · Cited by 41 · see citing works

Inhibition of MEK/ERK1/2 Signaling Affects the Fatty Acid Composition of HepG2 Human Hepatic Cell Line

Yousefi, B., Darabi, M., Baradaran, B., Khaniani, M. S., Rahbani, M., Darabi, M., Fayezi, S., Mehdizadeh, A., Saliani, N., & Shaaker, M. (2012) · Europe PMC (PubMed Central) · doi:10.5681/bi.2012.019 · Cited by 40 · see citing works

Biotransformation pathway maps in WikiPathways enable direct visualization of drug metabolism related expression changes

Jennen, D. G. J., Gaj, S., Giesbertz, P., van Delft, J. H. M., Evelo, C. T., & Kleinjans, J. C. S. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.08.002 · Cited by 40 · see citing works

Transcriptional and Epigenetic Consequences of DMSO Treatment on HepaRG Cells

Dubois‐Pot‐Schneider, H., Aninat, C., Kattler, K., Fekir, K., Jarnouen, K., Cérec, V., Glaise, D., Salhab, A., Gasparoni, G., Takashi, K., et al. (2022) · Cells · doi:10.3390/cells11152298 · Cited by 39 · see citing works

In vitro testicular toxicity models: Opportunities for advancement via biomedical engineering techniques

Parks, L. G. (2013) · ALTEX · doi:10.14573/altex.2013.3.353 · Cited by 39 · see citing works

Cytostatic and genotoxic effect of temephos in human lymphocytes and HepG2 cells

Benítez-Trinidad, A. B., Herrera‐Moreno, J. F., Vázquez-Estrada, G., Verdín-Betancourt, F. A., Sordo, M., Ostrosky‐Wegman, P., Bernal-Hernández, Y. Y., Medina‐Díaz, I. M., Barrón-Vivanco, B. S., Robledo-Marenco, M. L., et al. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2015.02.008 · Cited by 39 · see citing works

Comparative genotoxicity of nanosilver in human liver HepG2 and colon Caco2 cells evaluated by fluorescent microscopy of cytochalasin B‐blocked micronucleus formation

Sahu, S. C., Roy, S. K., Zheng, J., Yourick, J. J., & Sprando, R. L. (2014) · Journal of Applied Toxicology · doi:10.1002/jat.3028 · Cited by 37 · see citing works

Carcinogens induce loss of the primary cilium in human renal proximal tubular epithelial cells independently of effects on the cell cycle

Radford, R., Slattery, C., Jennings, P., Blacque, O. E., Pfaller, W., Gmuender, H., van Delft, J. H. M., Ryan, M. P., & McMorrow, T. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00427.2011 · Cited by 36 · see citing works

Performance of HepaRG and HepG2 cells in the high-throughput micronucleus assay for in vitro genotoxicity assessment

Guo, X., Seo, J., Petibone, D. M., Tryndyak, V., Lee, U. J., Zhou, T., Robison, T. W., & Mei, N. (2020) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2020.1822972 · Cited by 37 · see citing works

Integration of new approach methods for the assessment of data-poor chemicals

Friedman, K. P., Thomas, R. S., Wambaugh, J. F., Harrill, J., Judson, R., Shafer, T. J., Williams, A. J., Lee, J.-Y. J., Loo, L., Gagné, M., et al. (2025) · Toxicological Sciences · doi:10.1093/toxsci/kfaf019 · Cited by 36 · see citing works

Comparative genotoxicity of nanosilver in human liver HepG2 and colon Caco2 cells evaluated by a flow cytometric in vitro micronucleus assay

Sahu, S. C., Njoroge, J. M., Bryce, S. M., Yourick, J. J., & Sprando, R. L. (2014) · Journal of Applied Toxicology · doi:10.1002/jat.3065 · Cited by 36 · see citing works

Comparison of MeHg-induced toxicogenomic responses across in vivo and in vitro models used in developmental toxicology

Robinson, J. F., Theunissen, P. T., van Dartel, D. A. M., Pennings, J. L. A., Faustman, E. M., & Piersma, A. H. (2011) · Reproductive Toxicology · doi:10.1016/j.reprotox.2011.05.011 · Cited by 36 · see citing works

Tea and coffee consumption in relation to DNA methylation in four European cohorts

Ek, W. E., Tobi, E. W., Ahsan, M., Lampa, E., Ponzi, E., Kyrtopoulos, S. Α., Georgiadis, P., Lumey, L. H., Heijmans, B. T., Botsivali, M., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx194 · Cited by 35 · see citing works

Generation of cytochrome P450 3A4-overexpressing HepG2 cell clones for standardization of hepatocellular testosterone 6β-hydroxylation activity

Herzog, N., Katzenberger, N., Martin, F., Schmidtke, K., & Kocks, J. W. H. (2015) · Journal of Cellular Biotechnology · doi:10.3233/jcb-15002 · Cited by 34 · see citing works

Interactions between hepatitis B virus and aflatoxin B1: effects on p53 induction in HepaRG cells

Lereau, M., Gouas, D. A., Villar, S., Nia, A. B., Hautefeuille, A. H., Berthillon, P., Martel-Planche, G., da Costa, A. N., Ortiz‐Cuaran, S., Hantz, O., et al. (2011) · Journal of General Virology · doi:10.1099/vir.0.032482-0 · Cited by 34 · see citing works

Flow cytometric micronucleus assay and TGx-DDI transcriptomic biomarker analysis of ten genotoxic and non-genotoxic chemicals in human HepaRG™ cells

Buick, J. K., Williams, A., Gagné, R., Swartz, C. D., Recio, L., Ferguson, S., & Yauk, C. L. (2020) · Genes and Environment · doi:10.1186/s41021-019-0139-2 · Cited by 34 · see citing works

RNA modifications as emerging therapeutic targets

Çayır, A. (2021) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1702 · Cited by 34 · see citing works

Phase 1 and Phase 2 Drug Metabolism and Bile Acid Production of HepaRG Cells in a Bioartificial Liver in Absence of Dimethyl Sulfoxide

Hoekstra, R., Nibourg, G. A. A., van der Hoeven, T. V., Plomer, G., Seppen, J., Ackermans, M. T., Camus, S., Kulik, W., van Gulik, T. M., Elferink, R. P. J. O., et al. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.049098 · Cited by 33 · see citing works

Effects of arsenic and heavy metals on metabolic pathways in cells of human origin: Similarities and differences

Fatema, K., Shoily, S. S., Ahsan, T., Haidar, Z., Sumit, A. F., & Sajib, A. A. (2021) · Toxicology Reports · doi:10.1016/j.toxrep.2021.05.015 · Cited by 33 · see citing works

Dietary lipids modulate methylmercury toxicity in Atlantic salmon

Olsvik, P. A., Amlund, H., & Torstensen, B. E. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.09.025 · Cited by 33 · see citing works

Effect of aflatoxin B1, benzo[a]pyrene, and methapyrilene on transcriptomic and epigenetic alterations in human liver HepaRG cells

Tryndyak, V., Kindrat, I., Dreval, K., Churchwell, M. I., Beland, F. A., & Pogribny, I. P. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.08.034 · Cited by 32 · see citing works

Extracts of Passive Samplers Deployed in Variably Contaminated Wetlands in the Athabasca Oil Sands Region Elicit Biochemical and Transcriptomic Effects in Avian Hepatocytes

Mundy, L. J., Williams, K. L., Chiu, S., Pauli, B. D., & Crump, D. (2019) · Environmental Science & Technology · doi:10.1021/acs.est.9b02066 · Cited by 32 · see citing works

Effects of short-chain per- and polyfluoroalkyl substances (PFAS) on human cytochrome P450 (CYP450) enzymes and human hepatocytes: An in vitro study

Solan, M. E., & Lavado, R. (2023) · Current Research in Toxicology · doi:10.1016/j.crtox.2023.100116 · Cited by 33 · see citing works

Chemical-based risk assessment and in vitro models of human health effects induced by organic pollutants in soils from the Olona valley

Baderna, D., Colombo, A., Amodei, G., Cantù, S., Teoldi, F., Cambria, F., Rotella, G., Natolino, F., Lodi, M., & Benfenati, E. (2013) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2013.06.088 · Cited by 31 · see citing works

Flow cytometric evaluation of the contribution of ionic silver to genotoxic potential of nanosilver in human liver HepG2 and colon Caco2 cells

Sahu, S. C., Njoroge, J. M., Bryce, S. M., Zheng, J., & Ihrie, J. (2016) · Journal of Applied Toxicology · doi:10.1002/jat.3276 · Cited by 31 · see citing works

Biocompatibility assessment of functionalized magnetic mesoporous silica nanoparticles in human HepaRG cells

Pisani, C., Rascol, E., Dorandeu, C., Charnay, C., Guari≠, Y., Chopineau, J., Devoisselle, J., & Prat, O. (2017) · Nanotoxicology · doi:10.1080/17435390.2017.1378749 · Cited by 30 · see citing works

Contribution of ionic silver to genotoxic potential of nanosilver in human liver HepG2 and colon Caco2 cells evaluated by the cytokinesis‐block micronucleus assay

Sahu, S. C., Roy, S. K., Zheng, J., & Ihrie, J. (2016) · Journal of Applied Toxicology · doi:10.1002/jat.3279 · Cited by 29 · see citing works

The application of omics-based human liver platforms for investigating the mechanism of drug-induced hepatotoxicity in vitro

Jiang, J., Pieterman, C., Ertaylan, G., Peeters, R., & de Kok, T. M. C. M. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02585-5 · Cited by 31 · see citing works

Advanced In Vitro HepaRG Culture Systems for Xenobiotic Metabolism and Toxicity Characterization

Ashraf, M. N., Asghar, M. W., Rong, Y., Doschak, M. R., & Kiang, T. K. L. (2018) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-018-0533-3 · Cited by 29 · see citing works

The Carcinogenome Project: In Vitro Gene Expression Profiling of Chemical Perturbations to Predict Long-Term Carcinogenicity

Li, A., Lü, X., Natoli, T. E., Bittker, J. A., Sipes, N. S., Subramanian, A., Auerbach, S. S., Sherr, D. H., & Monti, S. (2019) · Environmental Health Perspectives · doi:10.1289/ehp3986 · Cited by 28 · see citing works

Prolonged Low-Dose Dioxin Exposure Impairs Metabolic Adaptability to High-Fat Diet Feeding in Female but Not Male Mice

Matteo, G., Hoyeck, M. P., Blair, H. L., Zebarth, J., Rick, K. R. C., Williams, A., Gagné, R., Buick, J. K., Yauk, C. L., & Bruin, J. E. (2021) · Endocrinology · doi:10.1210/endocr/bqab050 · Cited by 28 · see citing works

Hepatic Transcriptome Responses of Domesticated and Wild Turkey Embryos to Aflatoxin B1

Monson, M. S., Cardona, C. J., Coulombe, R. A., & Reed, K. M. (2016) · Toxins · doi:10.3390/toxins8010016 · Cited by 28 · see citing works

Transcriptomic alterations induced by aflatoxin B1 and ochratoxin A in LMH cell line

Choi, S.-Y., Kim, T. H., Hong, M.-W., Park, T. S., Lee, H., & Lee, S. (2020) · Poultry Science · doi:10.1016/j.psj.2020.05.058 · Cited by 28 · see citing works

C9orf16 (BBLN) gene, encoding a member of Hero proteins, is a novel marker in ischemic stroke risk

Kobzeva, K., Shilenok, I. V., Белых, А. Е., Gurtovoy, D. E., Bobyleva, L. A., Krapiva, A. B., Stetskaya, T. A., Быканова, М. А., Mezhenskaya, A. A., Lysikova, E. A., et al. (2022) · RESEARCH RESULTS IN BIOMEDICINE · doi:10.18413/2658-6533-2022-8-3-0-2 · Cited by 27 · see citing works

Toxicogenomics of drug induced liver injury – from mechanistic understanding to early prediction.

Lauschke, V. M. (2021) · Drug Metabolism Reviews · doi:10.1080/03602532.2021.1894571 · Cited by 26 · see citing works

Association between HSPA8 Gene Variants and Ischemic Stroke: A Pilot Study Providing Additional Evidence for the Role of Heat Shock Proteins in Disease Pathogenesis

Kobzeva, K., Soldatova, M. O., Stetskaya, T. A., Soldatov, V. O., Deykin, A. V., Freidin, M. B., Быканова, М. А., Churnosov, M. I., Polonikov, A., & Bushueva, O. Y. (2023) · Genes · doi:10.3390/genes14061171 · Cited by 26 · see citing works

Lophirones B and C prevent aflatoxin B1-induced oxidative stress and DNA fragmentation in rat hepatocytes

Ajiboye, T. O., Yakubu, M. T., & Oladiji, A. T. (2016) · Pharmaceutical Biology · doi:10.3109/13880209.2015.1137603 · Cited by 26 · see citing works

Comprehensive assessment of Cucurbitacin E related hepatotoxicity and drug-drug interactions involving CYP3A and P-glycoprotein

Lu, J., Zhang, Y., Sun, M., Liu, M., & Wang, X. (2017) · Phytomedicine · doi:10.1016/j.phymed.2017.01.004 · Cited by 25 · see citing works

Opportunities for an alternative integrating testing strategy for carcinogen hazard assessment?

Doktorova, T. Y., Pauwels, M., Vinken, M., Vanhaecke, T., & Rogiers, V. (2011) · Critical Reviews in Toxicology · doi:10.3109/10408444.2011.623151 · Cited by 25 · see citing works

Interactive toxicity of usnic acid and lipopolysaccharides in human liver HepG2 cells

Sahu, S. C., O'Donnell, M. W., & Sprando, R. L. (2012) · Journal of Applied Toxicology · doi:10.1002/jat.2768 · Cited by 24 · see citing works

Reprogramming of the HepG2 genome by long interspersed nuclear element‐1

Bojang, P., Roberts, R. A., Anderton, M. J., & Ramos, K. S. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.04.003 · Cited by 24 · see citing works

Evaluating microRNA profiles reveals discriminative responses following genotoxic or non-genotoxic carcinogen exposure in primary mouse hepatocytes

Rieswijk, L., Brauers, K. J. J., Coonen, M. L. J., Breda, S. G. J. V., Jennen, D. G. J., & Kleinjans, J. C. S. (2015) · Mutagenesis · doi:10.1093/mutage/gev036 · Cited by 23 · see citing works

Interindividual variation in response to xenobiotic exposure established in precision-cut human liver slices

Jetten, M. J. A., Claessen, S. M. H., Dejong, C. H. C., Lahoz, A., Castell, J. V., van Delft, J. H. M., & Kleinjans, J. C. S. (2014) · Toxicology · doi:10.1016/j.tox.2014.06.007 · Cited by 23 · see citing works

Cyclosporine A treated in vitro models induce cholestasis response through comparison of phenotype-directed gene expression analysis of in vivo Cyclosporine A-induced cholestasis

Kienhuis, A. S., Vitins, A. P., Pennings, J. L. A., Pronk, T. E., Speksnijder, E. N., Roodbergen, M., van Delft, J. H. M., Luijten, M., & van der Ven, L. T. M. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.06.236 · Cited by 22 · see citing works

Mycotoxins as Food Carcinogens

Vettorazzi, A., & de Ceráin, A. L. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-411471-5.00017-x · Cited by 20 · see citing works

Baseline and genotoxic compound induced gene expression profiles in HepG2 and HepaRG compared to primary human hepatocytes

Jetten, M. J. A., Kleinjans, J. C. S., Claessen, S. M. H., Chesné, C., & van Delft, J. H. M. (2013) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.07.010 · Cited by 57 · see citing works

Transcriptomic responses generated by hepatocarcinogens in a battery of liver-based in vitro models

Doktorova, T. Y., Yildirimman, R., Vinken, M., Vilardell, M., Vanhaecke, T., Gmuender, H., Bort, R., Brolén, G., Holmgren, G., Li, R., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt054 · Cited by 55 · see citing works

Predictive toxicogenomics for the identification of chemical carcinogens : application to human hepatic cell lines

Magkoufopoulou, C. (2011) · doi:10.26481/dis.20111208cc

Testing chemical carcinogenicity by using a transcriptomics HepaRG-based model?

Doktorova, T. Y., Yildirimman, R., Ceelen, L. M., Vilardell, M., Vanhaecke, T., Vinken, M., Ates, G., Heymans, A., Gmuender, H., Bort, R., et al. (2014) · Europe PMC (PubMed Central) · doi:10.17877/de290r-857 · Cited by 24 · see citing works

Original article: TESTING CHEMICAL CARCINOGENICITY BY USING A TRANSCRIPTOMICS HEPARG-BASED MODEL?

Doktorova, T. Y., Yildirimman, R., Ceelen, L. M., Vilardell, M., Vinken, M., Ates, G., Heymans, A., Gmuender, H., Corvi, R., Phrakonkham, P., et al. (2016)